DK0862634T3 - Pharmaceutical preparation for papillomavirus tumors and infections - Google Patents

Pharmaceutical preparation for papillomavirus tumors and infections

Info

Publication number
DK0862634T3
DK0862634T3 DK97935646T DK97935646T DK0862634T3 DK 0862634 T3 DK0862634 T3 DK 0862634T3 DK 97935646 T DK97935646 T DK 97935646T DK 97935646 T DK97935646 T DK 97935646T DK 0862634 T3 DK0862634 T3 DK 0862634T3
Authority
DK
Denmark
Prior art keywords
infections
pharmaceutical preparation
polypeptide
iii
papillomavirus
Prior art date
Application number
DK97935646T
Other languages
Danish (da)
Other versions
DK0862634T4 (en
Inventor
Jean-Marc Balloul
Nadine Bizouarne
Marie-Paule Kieny
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9494633&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0862634(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of DK0862634T3 publication Critical patent/DK0862634T3/en
Publication of DK0862634T4 publication Critical patent/DK0862634T4/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Abstract

Composition (A) for treating or preventing infections or tumours caused by papilloma virus (PV) contains as active ingredient: (a) ≥ 1 polypeptide (I) from the early region of PV and ≥ 1 polypeptide (II) from the late region of PV, or (b) ≥ 1 (I) and/or (II) plus a polypeptide (III) with immunostimulating activity. Also claimed are similar compositions containing vectors having inserts that encode (I)-(III).
DK97935646T 1996-07-30 1997-07-29 Pharmaceutical preparation for papillomavirus tumors and infections DK0862634T4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9609584A FR2751879B1 (en) 1996-07-30 1996-07-30 PHARMACEUTICAL COMPOSITION AGAINST TUMORS AND PAPILLOMAVIRUS INFECTIONS
PCT/FR1997/001412 WO1998004705A1 (en) 1996-07-30 1997-07-29 Pharmaceutical composition for treating papillomavirus tumours and infection

Publications (2)

Publication Number Publication Date
DK0862634T3 true DK0862634T3 (en) 2002-01-21
DK0862634T4 DK0862634T4 (en) 2006-05-08

Family

ID=9494633

Family Applications (2)

Application Number Title Priority Date Filing Date
DK01109013T DK1149910T3 (en) 1996-07-30 1997-07-29 Pharmaceutical preparation for treating papillomavirus tumors and infection
DK97935646T DK0862634T4 (en) 1996-07-30 1997-07-29 Pharmaceutical preparation for papillomavirus tumors and infections

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK01109013T DK1149910T3 (en) 1996-07-30 1997-07-29 Pharmaceutical preparation for treating papillomavirus tumors and infection

Country Status (12)

Country Link
EP (2) EP0862634B2 (en)
JP (2) JP4070815B2 (en)
AT (2) ATE265535T1 (en)
AU (1) AU736720B2 (en)
CA (1) CA2234263C (en)
DE (2) DE69728914T2 (en)
DK (2) DK1149910T3 (en)
ES (2) ES2163795T5 (en)
FR (1) FR2751879B1 (en)
HK (1) HK1043809B (en)
PT (2) PT1149910E (en)
WO (1) WO1998004705A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7182947B2 (en) 1998-02-20 2007-02-27 Medigene Ag Papillomavirus truncated L1 protein and fusion protein constructs
CA2229955C (en) 1998-02-20 2003-12-09 Medigene Gmbh Papilloma virus capsomere vaccine formulations and methods of use
US7494658B2 (en) 1998-02-20 2009-02-24 Medigene Ag Papilloma virus truncated L1 protein and fusion protein constructs
US20020039584A1 (en) 1998-02-20 2002-04-04 Medigene Ag Papilloma virus capsomere vaccine formulations and methods of use
US6926897B1 (en) 1998-03-24 2005-08-09 Medigene Aktiengesellschaft Medicament for the avoidance or treatment of papillomavirus-specific tumour
CA2335506A1 (en) * 1998-06-26 2000-01-06 Aventis Pasteur Mucosal targeting immunisation
US8058049B2 (en) 2006-06-20 2011-11-15 Transgene S.A. Process for producing poxviruses and poxvirus compositions
KR20110116016A (en) 2009-01-20 2011-10-24 트랜스진 에스.에이. Soluble icam-1 as biomarker for prediction of therapeutic response
SG2014014021A (en) 2009-03-24 2014-07-30 Transgene Sa Biomarker for monitoring patients
CN102395883B (en) 2009-04-17 2015-12-02 特朗斯吉有限公司 For the biomarker of monitored patient
EP2429579A1 (en) 2009-05-12 2012-03-21 Transgene SA Immortalized avian cell lines and use thereof
CN102483405B (en) 2009-07-10 2015-12-02 特朗斯吉有限公司 For selecting biomarker and the correlation technique of patient
KR20120089245A (en) 2009-07-21 2012-08-09 트랜스진 에스.에이. Enzymatic composition for the digestion of chicken embryos
TWI690322B (en) 2012-10-02 2020-04-11 法商傳斯堅公司 Virus-containing formulation and use thereof
ES2753364T3 (en) 2014-12-01 2020-04-08 Transgene Sa Stable liquid formulations of vaccinia virus
FR3042121A1 (en) * 2015-10-08 2017-04-14 Jean-Marc Limacher ANTI-TUMOR COMPOSITION
CA3062549A1 (en) 2017-05-15 2018-11-22 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
EP3624851A1 (en) 2017-05-15 2020-03-25 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
JP7437385B2 (en) 2018-09-06 2024-02-22 バヴァリアン・ノルディック・アクティーゼルスカブ Poxvirus composition with improved storage
CN115243717A (en) 2020-03-12 2022-10-25 巴法里安诺迪克有限公司 Compositions for improving poxvirus stability

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2643817B1 (en) * 1989-03-06 1993-12-17 Transgene Sa PHARMACEUTICAL COMPOSITION, USEFUL AS A PREVENTIVE OR CURATIVE AGAINST TUMORS INDUCED BY PAPILLOMAVIRUS
KR910016343A (en) † 1990-03-20 1991-11-05 스타인, 부그 Serum Reactive Epitopes of Human Papillomavirus (HPV) 16 Protein
GB9113809D0 (en) * 1991-06-26 1991-08-14 Cancer Res Campaign Tech Papillomavirus l2 protein
DE122007000018I1 (en) * 1991-07-19 2007-05-24 Univ Queensland Polynucleotide portion of the HPV16 genome
US5618536A (en) * 1992-09-03 1997-04-08 The United States Of America As Represented By The Department Of Health And Human Services Chimeric papillomavirus-like particles
GB9306731D0 (en) * 1993-03-31 1993-05-26 Cancer Res Campaign Tech Vaccines
IL113817A (en) * 1994-06-30 2001-03-19 Merck & Co Inc Polynucleotide vaccne for papillomavirus
AU712714B2 (en) * 1994-10-03 1999-11-11 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule B7 gene in a recombinant virus expressing system
GB9505784D0 (en) * 1995-03-22 1995-05-10 Lynxvale Ltd Anti-tumour treatment
FR2749323B1 (en) * 1996-06-04 1998-07-10 Pasteur Merieux Serums Vacc PSEUDO-PARTICLES VIRALES USEFUL AS A VECTOR OF NUCLEIC ACID DELIVERY

Also Published As

Publication number Publication date
EP1149910B1 (en) 2004-04-28
ATE205881T1 (en) 2001-10-15
ES2215805T3 (en) 2004-10-16
CA2234263C (en) 2009-10-13
DK0862634T4 (en) 2006-05-08
ES2163795T3 (en) 2002-02-01
ATE265535T1 (en) 2004-05-15
FR2751879B1 (en) 1998-10-30
DK1149910T3 (en) 2004-08-02
EP0862634A1 (en) 1998-09-09
FR2751879A1 (en) 1998-02-06
DE69728914T2 (en) 2005-04-07
WO1998004705A1 (en) 1998-02-05
JP4198735B2 (en) 2008-12-17
DE69706825T2 (en) 2002-05-02
HK1043809A1 (en) 2002-09-27
EP0862634B1 (en) 2001-09-19
PT1149910E (en) 2004-09-30
AU736720B2 (en) 2001-08-02
JP2000500662A (en) 2000-01-25
EP1149910A1 (en) 2001-10-31
CA2234263A1 (en) 1998-02-05
EP0862634B2 (en) 2006-03-01
AU3855297A (en) 1998-02-20
DE69728914D1 (en) 2004-06-03
DE69706825D1 (en) 2001-10-25
HK1043809B (en) 2004-12-03
JP2007254474A (en) 2007-10-04
ES2163795T5 (en) 2006-07-16
JP4070815B2 (en) 2008-04-02
PT862634E (en) 2002-03-28
DE69706825T3 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
DK0862634T4 (en) Pharmaceutical preparation for papillomavirus tumors and infections
UA39158C2 (en) derivatives of N4-oxycarbonyl- 5'-deoxy-5-fluorocytidine and pharmaceutical preparation based thereon
DE69729786D1 (en) HIGHLY CONCENTRATED, LYOPHILIZED AND LIQUID FACTOR IX FORMULATIONS
NO924172L (en) SUBSTITUTED BIFENYL PYRIDONES
FI891361A (en) Process for the preparation of pharmaceutically active arylhydrazones
EA200200479A1 (en) NEW OLIGOSACCHARIDES, THEIR RECEIVING AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
AU589939B2 (en) Medical composition for injection containing a spergualin as active ingredient and process for preparing the same
FI923347A (en) BLODFAKTORER PRODUCERADE MED REKOMBINANT-DNA-TEKNIK OCH FOERFARANDE FOER EXPRESSION AV NAEMNDA BLODFAKTORER SAMT I NAEMNDA FOERFARANDE ANVAENDA REKOMBINANTA KOKOPPVIRUS.
UA50808C2 (en) Composition for treatment of irds and ards
CS156792A3 (en) Substituted diaminophthalimides and compounds analogous thereto
KR0180256B1 (en) Bpc peptides, their preparation and use
MD502G2 (en) New adenozine derivatives, methods of obtainitg thereof, farmaceutical compositions on the base thereof
CA2263846A1 (en) Novel pyranoside derivatives
EP0127124A3 (en) Compounds for treating hypertension
MY101169A (en) Novel phenylureas
EP1074264A4 (en) Neovascularization inhibitors
AU6722498A (en) Disubstituted biphenyloxazolines
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
RU94019328A (en) α- HETEROARILOXYMETYLKETONES, PHARMACEUTICAL COMPOSITION, INHIBITING INTERLEUKIN-1 - β-PROTEASIS
IT1230053B (en) COMPOSITION FOR THE INCREASE OF THE WEIGHT GAIN.
IT8619383A0 (en) NEW COMPOUNDS WITH CHOLINERGIC ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
IT8619384A0 (en) COMPOUNDS WITH HEPATOPROTECTIVE AND MUCOLYTIC ACTIVITIES, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
CA2234611A1 (en) New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions